We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Kit Purifies RNA from Very Small Samples

By LabMedica International staff writers
Posted on 29 Apr 2015
Print article
The GeneChip WT Pico Kit for gene expression array target preparation from very small samples
The GeneChip WT Pico Kit for gene expression array target preparation from very small samples (Photo courtesy of )
A new kit for RNA purification prior to microarray analysis was designed specifically for small samples and for particularly difficult to isolate targets such as subpopulations of cells within larger samples like those found in heterogeneous solid tumors or hematologic malignancies.

Traditional whole-transcriptome expression analysis depends on samples derived from a relatively large number of cells. However, the gene expression measurements from these large cell populations represent an average that can often mask key differences between subpopulations. To better understand the biological significance of these differences in gene expression, researchers are increasingly focusing on smaller, characterized subsets of cells.

To accommodate these researchers Affymetrix (Santa Clara, CA, USA) developed the GeneChip WT Pico Kit for gene expression array target preparation, which can be used with as little as 100 picograms of total RNA, the amount that can be obtained from about 10 cells.

The new WT Pico Kit is compatible with small sample isolation techniques, including flow cytometry, laser capture microdissection, and fine needle aspiration. The kit prepares targets from multiple sample types, including fresh and fresh frozen tissues, cultured cells, FFPE specimens, and whole blood samples without a globin mRNA reduction step.

“In addition to conserving samples and enabling analysis of samples that may only contain small amounts of RNA, the ability to zero in on smaller sets of cells can reveal information that is hidden in larger cell populations,” said Christian Reece, product manager at Affymetrix. “Cancer researchers working with solid tumors and hematologic malignancies are particularly interested at looking at smaller and smaller groups of cells.”

Related Links:

Affymetrix


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Unit-Dose Packaging solution
HLX
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Automated Nucleic Acid Extractor
eLab
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.